Treadwell Therapeutics
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $118M
Investors
- 6
About Treadwell Therapeutics
Treadwell Therapeutics, Inc. is a biotechnology company focused on developing innovative oncology treatments.Treadwell Therapeutics, Inc. specializes in the development of oncology therapeutics targeting significant gaps in cancer treatment. Founded by Mark Bray and Shane Burgess, the company is headquartered in New York, US.Treadwell Therapeutics specializes in the development of innovative oncology treatments, focusing on a pipeline of first-in-class therapies designed to address significant unmet needs in cancer care. The company's core offerings include small molecules, biologics, and T-cell receptor-based cell therapies, all developed using a science-first approach to target novel therapeutic interventions. These therapies aim to provide effective treatment options for patients facing cancers with limited existing solutions. Treadwell Therapeutics targets healthcare providers, cancer treatment centers, and hospitals, serving patients who require advanced and personalized cancer therapies.Treadwell Therapeutics generates revenue through partnerships with healthcare institutions and biopharmaceutical companies, focusing on collaborative clinical trials and research initiatives. The company engages in B2B transactions with hospitals and cancer treatment centers, where its therapies are integrated into treatment protocols for patients. Revenue is structured around agreements for access to its clinical candidates and potentially through licensing arrangements for successful products. Specific pricing plans are tailored to reflect the nature of the partnerships and the complexity of the therapies involved, ensuring that healthcare providers have access to cutting-edge treatments as they become available. The company is focused on advancing its pipeline of therapies and aims to expand its market presence in North America and Europe. As part of its growth strategy, Treadwell is exploring opportunities to launch new products and is committed to enhancing its clinical trial activities to bring innovative solutions to patients in need.
Who invested in Treadwell Therapeutics
6 investors across 2 rounds
See all investors in Treadwell Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Treadwell Therapeutics
Who invested in Treadwell Therapeutics?
Treadwell Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Treadwell Therapeutics raised?
Treadwell Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Treadwell Therapeutics last raise money?
Treadwell Therapeutics's most recent round on record is a Series B, in Nov 2021.
What does Treadwell Therapeutics do?
Treadwell Therapeutics is a pharmaceuticals company.
Where is Treadwell Therapeutics headquartered?
Treadwell Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Treadwell Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Treadwell Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Treadwell Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.